24 January 2024 in Inorganic Chemistry
31 January 2024 in ACS Organic & Inorganic Au
The industrial production of methanol through CO hydrogenation using the Cu/ZnO/Al2O3 catalyst requires harsh conditions, and the development of new catalysts with low operating temperatures is highly desirable. In this study, organic biomimetic FLP catalysts with good tolerance to CO poison are theoretically designed. The base-free catalytic reaction contains the 1,1-addition of CO into a formic acid intermediate and the hydrogenation of the formic acid intermediate into methanol. Low-energy spans (25.6, 22.1, and 20.6 kcal/mol) are achieved, indicating that CO can be hydrogenated into methanol at low temperatures. The new extended aromatization-dearomatization effect involving multiple rings is proposed to effectively facilitate the rate-determining CO 1,1-addition step, and a new CO activation model is proposed for organic catalysts.
8 July 2025 in Inorganic Chemistry
A new reactivity of SO2 to form unusual stable M-X-SO2 (X = F, Cl, H) complexes is unveiled in this study. Moreover, a new type of S-X long bonds, which are significantly longer than traditional S-X covalent bonds, has been discovered. The P,N-ligated Ni-F complex model 1A can bind a SO2 molecule through the new F-S long bond (2.207 Å), and a stable Ni-F-SO2 complex 1B is generated, being exergonic by 2.2 kcal/mol. According to natural localized molecular orbital analysis, the new S-F long bond has a unique p(F) → π*(O═S═O) bonding interaction, which is shown to arise from the long S-F length. In comparison, the strength of the new F-S long bond (-2.2 kcal/mol) is found to be significantly stronger than common noncovalent interactions such as the hydrogen and halogen bond. The substituent modulations suggest that the electron-donating groups can increase the strength of new F-S bonds and enhance binding free energies ΔGbind. The scope of possible M-X complexes was explored, and various metals and X (F, Cl, and H) ligands were found to form stable M-X-SO2 complexes. Specifically, the anionic M-X complexes display much higher ΔGbind values, ranging from -8 to -10 kcal/mol. The study paves the way for a green, recyclable, and adjustable SO2 absorption method.
18 September 2023 in Inorganic Chemistry Frontiers
Venous thromboembolism caused by Pt(II)-based chemotherapy regimens increases the risk of colon cancer metastasis, recurrence, and treatment failure. Therefore, the reduction of tumor thrombosis during chemotherapy has received much attention. Herein, a series of Pt(IV) hybrids based on the TXA2R antagonist seratrodast (SRT) were synthesized and named Seratplatin. Bioactivity studies found that compounds 3 and 4 had stronger cytotoxicity and selectivity against cancer cells among four SRT-derived Pt(IV) complexes, especially compound 3, which demonstrated a nanomolar IC50 value and 42-fold lower than that in CDDP. Studies on the mechanism indicated that the cisplatin-like prodrugs are accumulated more in cells, but only compound 3 with rapid reducing properties could induce severe DNA damage, ROS production, S-phase arrest, and cell apoptosis. Most strikingly, 3 had a higher binding affinity than SRT alone or the other three derivatives and effectively inhibited the expression of TXA2R at a dose of only 0.1 times that of free SRT, thereby preventing platelet aggregation and tumor thrombosis. Compound 3 exerted anti-metastasis, anti-invasion, and anti-angiogenesis via the down-regulation of vimentin, VEGFA, MMP-9, and up-regulation of E-cadherin. In in vivo tests, compound 3 displayed a high anti-tumor effect without significant weight changes or tissue damage in HCT-116 tumor-bearing mice. Overall, these findings shed light on the special therapeutic effects of SRT-derived Pt(IV) prodrugs for cancer therapy.
1 January 2020 in Journal of Risk Analysis and Crisis Response
In the current complex and uncertainty of the risk of COVID-19 in long-term care facilities, the elderly in the long-term care facilities are at the highest risk of being affected by COVID-19. There is still uncertain relationship between the identification of this risk and the care management, caring behavior, cannot achieve management optimization. Matrix analysis the change relation between the conditions for the COVID-19 risk identification and risk behavior. The results show that there are N equilibrium points for the risk management of COVID-19 in long-term care facilities. The complexity of the risk of COVID-19 in long-term care facilities and the cognitive deviations caused by the limited rationality of managers and caregivers make the COVID-19, the risk early warning system is not easy to converge to a stable point in the real environment, so as to achieve the best management status of the COVID-19 risk in long-term care facilities. Nursing staff behavior, risk management cost, risk loss and other parameters have different risk management effects for the COVID-19. When the selected parameter is adjusted through the threshold, reflects the stability and selection tendency of the COVID-19 risk management strategy. Promote institutional managers and caregivers to adopt active risk management strategies: Strengthen the awareness of institutional managers and caregivers about the complexity and uncertainty of risks; Optimize the COVID-19 risk management system, process and procedures; Strengthen the research on risk accidents, serious consequences and effective prevention of COVID-19; Strengthen the review and supervision of the risk management of COVID-19 and improve its value perception of the effective prevention of the risk of COVID-19.